4-甲基-2-氨基喹啉-3-腈 | 28448-11-5

• 物质功能分类: 医药中间体 - 杂环化合物 - 喹啉类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 中文名称: 4-甲基-2-氨基喹啉-3-腈
• 中文别名: 2-氨基-4-甲基喹啉-3-腈；4-甲基-2-氨基-3-氰基喹啉
• 英文名称: 2-amino-4-methylquinoline-3-carbonitrile
• CAS: 28448-11-5
• 化学式: C₁₁H₉N₃
• mdl: MFCD01570320
• 分子量: 183.213
• InChiKey: DXXUIIMDJKUSES-UHFFFAOYSA-N

物化性质

• 沸点：
  399.1±42.0 °C(Predicted)
• 密度：
  1.24±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  14
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  62.7
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2933499090

反应信息

• 作为反应物：
  描述：

  4-甲基-2-氨基喹啉-3-腈 在 甲酸 、 五氯化磷 、 硫酸 、 一水合肼 、 三氯氧磷 作用下， 以 乙醇 为溶剂， 反应 7.5h， 生成 4-hydrazino-5-methyl-2,4-deoxo-5-deazaalloxazine
  参考文献：
  名称：

  Synthesis, characterization and reactions of 2-deoxo-5-deazaalloxazines

  摘要：

  5-Deazaflavins and their homologues. have been known as potential riboflavin antagonists, bioreductives, and compounds with potent antitumor activity. 2-Amino-4-methylquinoline-3-carbonitrile (2) was prepared as unreported starting material for several interesting 2-deoxo-5-deazalloxazine derivatives. Cyclization of 2 using formamide afforded the 2,4-deoxo-5-deazaalloxazine derivative 7, which was subjected to deamination with nitrous acid to give the 2-deoxo-5-deazaalloxazine (8). The compound 8 was also obtained via 13 by treating the latter with refluxing formic acid or formamide and used as a precursor for synthesis of several 2-deoxo-5-deazaalloxazines 18, 19, 20, 21 and 22. The pharmacological and biological properties of these compounds are still under investigation. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(01)00194-8
• 作为产物：
  描述：

  邻氨基苯乙酮 、 丙二腈 在 乙酸铵 、 溶剂黄146 作用下， 以 苯 为溶剂， 反应 0.17h， 以78%的产率得到4-甲基-2-氨基喹啉-3-腈
  参考文献：
  名称：

  Al-Omran, Fatima; Abdel-Khalik, Mervat Mohammed; Abou-Elkhair, Adel, Journal of Chemical Research, Miniprint, 1998, # 6, p. 1201 - 1214

  摘要：

  DOI：

文献信息

• Method of using aminocyanopyridine compounds as mitogen activated protein kinase-activated protein kinase-2 inhibitors
  申请人：Pharmacia Corporation

  公开号：US20040127519A1

  公开（公告）日：2004-07-01

  A method is described for inhibiting mitogen activated protein kinase-activated protein kinase-2 in a subject in need of such inhibition, where the method involves administering to the subject an anminocyanopyridine MK-2 inhibiting compound, or a pharmaceutically acceptable salt thereof.

  本文描述了一种抑制需要抑制的受试者中的有丝分裂原活化蛋白激酶激活蛋白激酶-2的方法，其中该方法涉及向受试者给予一种抑制MK-2的氨基氰基吡啶化合物或其药学上可接受的盐。
• Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
  申请人：Pharmacia Corporation

  公开号：US20040142978A1

  公开（公告）日：2004-07-22

  Aminocyanopyridine compounds are described which can inhibit mitogen activated protein kinase-activated protein kinase-2. Pharmaceutical compositions and kits that contain these compounds are also described.

  描述了可抑制丝裂原活化蛋白激酶-活化蛋白激酶-2 的氨基氰吡啶化合物。还描述了含有这些化合物的药物组合物和试剂盒。
• Al-Omran, Fatima; Abdel-Khalik, Mervat Mohammed; Abou-Elkhair, Adel, Journal of Chemical Research, Miniprint, 1998, # 6, p. 1201 - 1214
  作者：Al-Omran, Fatima、Abdel-Khalik, Mervat Mohammed、Abou-Elkhair, Adel、Elnagdi, Mohammed Hilmy

  DOI：——

  日期：——
• HIGASHINO T.; SUZUKI K.; HAYASHI E., CHEM. AND PHARM. BULL., 1978, 26, NO 11, 3485-3491
  作者：HIGASHINO T.、 SUZUKI K.、 HAYASHI E.

  DOI：——

  日期：——
• METHOD OF USING AMINOCYANOPYRIDINE COMPOUNDS AS MITOGEN ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE-2 INHIBITORS
  申请人：Pharmacia Corporation

  公开号：EP1569645A2

  公开（公告）日：2005-09-07